Picture of Theratechnologies logo

TH Theratechnologies News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Brief: Theratechnologies’ Shares Data Demonstrating Cost-Effectiveness Of Ibalizumab

Oct 19 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES’ IBALIZUMAB DEMONSTRATES
COST-EFFECTIVENESS AS
AN ADDITION TO ROUTINE CLINICAL CARE IN HEAVILY
TREATMENT-EXPERIENCED PEOPLE WITH HIV

Source text for Eikon:  ID:nGNX4QjC8r 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Theratechnologies

See all news